www.globalhealthhub.org
| 12 days ago
... of the worldwide AIDS epidemic,” a Food and Drug Administration (FDA) panel on Thursday recommended Gilead Sciences' antiretroviral drug Truvada be approved for pre-exposure prophylaxis (PrEP) to prevent HIV among healthy people ...
www.2540.org
| 12 days ago
United States since 2004. According to Gilead, it is currently the most-prescribed antiretroviral treatment in the US. The 22-member panel voted 19 to 3 in favor of approving the pill as a pre-exposure prophylaxis or PrEP in non-HIV-infected ...
b4tea.blogspot.com
| 12 days ago
The Antiviral Drugs Advisory Committee of FDA suggested the approval of pre-exposure prophylaxis (PrEP) drug for the healthy people of three groups: 1) men who have sex with men (gay), 2) heterosexual couples with one HIV-positive ...
www.burrillreport.com
| 12 days ago
Members of U.S. Food and Drug Administration's Antiviral Drugs Advisory Committee supported approving the drug for pre-exposure prophylaxis in men who have sex with men, helping HIV-free partners avoid infection in couples in which one ...
sciencespeaksblog.org
| 12 days ago
... application for Gilead Sciences' HIV drug Truvada (a combination of emtricitabine plus tenofovir) as pre-exposure prophylaxis (PrEP) be approved for high-risk, HIV-negative individuals to reduce the risk of sexually acquired HIV infection.
www.rawstory.com
| 12 days ago
Mitchell Warren, executive director of HIV prevention group AVAC, said after the vote that pre-exposure prophylaxis (PrEP), or the method of taking a drug ahead of potential exposure to HIV, “while not a panacea, will be an essential additional ...
www.manhuntcares.com
| 12 days ago
A similar vote—19-2, with one abstention—resulted in Truvada being recommended as as pre-exposure prophylaxis (PrEP) for HIV-negative partners in serodiscordant relationships. The closest vote—12 in favor and eight against, with two ...
www.snspost.com
| 12 days ago
Mitchell Warren, executive director of HIV prevention group AVAC, said after the vote that pre-exposure prophylaxis (PrEP), or the method of taking a drug ahead of potential exposure to HIV, “while not a panacea, will be an essential additional ...
